Alterity Therapeutics Limited Alterity Therapeutics Limited

Alterity Therapeutics Limited

ATH

Rankning i aktier #26200
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Aktiekurs
$0.18690047
Marknadsvärde
$40.84M
Förändring (1 dag)
3.92%
Förändring (1 år)
-46.60%
Land
AU
Handel Alterity Therapeutics Limited (ATH)

Kategori

Healthcare
Historik för aktiesplit för Alterity Therapeutics Limited (ATH)
Aktien Alterity Therapeutics Limited (symbol: ATH) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En ATH-aktie köpt före Oct 21, 2026 motsvarar nu 0 ATH-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL